The higher levels of IL-6 and CRP observed in patients with pneumonia compared with the other group may be associated with the release of inflammatory mediators from type 2 pneumocytes as the virus enters cells via the ACE2 receptor and undergoes replication [33]. Here, CRP is linked to susceptibility to pneumonia measurement.